R&D - Pharmaceutical Executive

ADVERTISEMENT

Click Here to take survey

Based on testimony heard on Monday, November 3, 2008, should the US Supreme Court side with Wyeth or Levine?
Wyeth
Levine
Wyeth
86%
Levine
14%

Corporate strategies and tactics for more effective drug development.

Gilding Lilly
November 1, 2008
Some say it's just another pharma facing its patent cliff. But others say this company's got it worse. With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?
Evolving Clinical Trials
October 1, 2008
Clinical trials need to change. A recent survey shows that industry should address the research supply chain for the greatest gains in effciency.
Publish or Perish
September 1, 2008
FDAAA means that you need to register clinical trials—and not only for publication planning
Unleash the Dragon 2
September 1, 2008
Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital.
In Praise of Independence: Q&A with Roche's Dan Zabrowski
March 1, 2008
Roche has always gone its own way with biologics, deals, and new medicines. Now that the rest of industry has caught on, how can Roche stay ahead of its time?
GSK Restructures Oncology Division
September 17, 2008
Roche Touts Positive Data for Investigational Diabetes Drug
June 11, 2008
Risky Cholesterol Drug Proves Positive for Roche
April 2, 2008
BioMS Medical Signs $500 Million Agreement with Lilly
January 9, 2008
Duke Partners with FDA to Modernize Clinical Trials
November 29, 2007
DRS TO HEALTH Healer's Gala
Nov 21, 2008
Westport, CT

ADVERTISEMENT

Daschle to Spearhead Healthcare Reform
Amid Big Pharma Woes, Shire in Best Shape Ever
Wyeth v. Levine: Inside the Preemption Case
HBA Leadership Conference: Day 2
Conversation with Eisais Lonnel Coats

ADVERTISEMENT

Events and Special Offers Gallery
Click here